Carlo Lazzaro - Publications

Managing severe gestational hypertension in Italy: a cost description.

Journal: Expert review of pharmacoeconomics & outcomes research

Published: August 12, 2026

GW240925 and GW250207: Astrophysical Calibration of Gravitational Wave Detectors.

Journal: Physical review letters

Published: January 27, 2026

Hydatidiform mole incidence in Lombardy, northern Italy, 2009-2022: continued decline or plateau?

Journal: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians

Published: October 07, 2025

Black Hole Spectroscopy and Tests of General Relativity with GW250114.

Journal: Physical review letters

Published: September 12, 2025

Cost-of-illness of myelodysplastic syndromes in Italy. A reply to Tse et al.

Journal: The European journal of health economics : HEPAC : health economics in prevention and care

Published: August 29, 2025

GW250114: Testing Hawking's Area Law and the Kerr Nature of Black Holes.

Journal: Physical review letters

Published: August 13, 2025

Expert review of pharmacoeconomics and outcomes research: high impact articles from 2024.

Journal: Expert review of pharmacoeconomics & outcomes research

Published: April 28, 2025

Relying solely on cost as a determinant of the economic value of a drug: Three major limitations. A reply to Murply et al., 2025.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: April 27, 2025

COVID-19-related hospitalizations in Italy: an application of the synthetic control method to investigate the trajectory of diagnosis-related group 79 and its counterfactual during 2010-2021.

Journal: Expert review of pharmacoeconomics & outcomes research

Published: March 21, 2025

Matters arising: On the cost-effectiveness for the Italian National Health Service of nab-paclitaxel plus gemcitabine vs gemcitabine alone in metastatic pancreatic cancer.

Journal: The Journal of the Egyptian Public Health Association

Published: September 07, 2024

On cost-effectiveness analysis, quality-adjusted life years, and cost-effectiveness threshold values of gemcitabine plus nab-paclitaxel versus gemcitabine alone in metastatic pancreatic cancer in the French setting.

Journal: Therapeutic advances in medical oncology

Published: July 16, 2024

Checking it (at least) twice may not be alright.

Journal: The Journal of asthma : official journal of the Association for the Care of Asthma

Published: May 31, 2024